The performance of Shire (LSE: SHP) (NASDAQ: SHPG.US) over the last year has been nothing short of phenomenal. In fact, the pharmaceutical companys shares have risen by an incredible 81% despite being the subject of a failed bid approach by US rival, AbbVie, which ended in a severe share price fall for Shire. Since then, though, the companys shares have risen strongly as investors look ahead to the potential for a doubling of Shires sales over the next five years.
However, despite its share price rise, Shire still offers excellent value for money. For example, it trades on a price to earnings growth (PEG) ratio of just 1.1, which indicates that its shares could continue to head northwards over the medium to long term. And, with the potential for further bids, Shire could receive a shorter term boost, too.
Rental equipment firm, Ashtead (LSE: AHT), continues to deliver stunning growth. In fact, its bottom line was 2.7 times bigger in 2014 than it was in 2012, which is an exceptional rate of growth that looks set to continue over the next couple of years.
For example, Ashtead is expected to increase earnings by 26% next year, and by a further 15% in the year after. Thats many times greater than the growth rate of the wider index and, despite this, Ashtead trades at only a relatively small premium to the wider index, with it having a price to earnings (P/E) ratio of 17.5 versus 16 for the FTSE 100. And, when its growth rate and rating are combined, it equates to a PEG ratio of just 0.8, which indicates that its share price could move higher at a rapid rate.
Over the next two years, building materials company, CRH (LSE: CRH), is forecast to deliver earnings growth of 48% and 31% respectively. Thats an incredibly high rate of growth and it could cause investor sentiment to rise significantly, thereby pushing the companys share price higher. And, with a significant margin of safety, new investors in the stock should have a degree of confidence in the future performance of CRHs shares, since even if its forecasts are downgraded somewhat, it still appears to offer excellent value for money.
For example, CRH trades on a P/E ratio of 20.8 which, when combined with its forecast growth rate, equates to a PEG ratio of just 0.5. This indicates that there is considerable upside and that, even if the macroeconomic outlook does deteriorate somewhat, CRH should still deliver an excellent amount of capital gain over the medium term.
Of course, finding growth stocks that are worth adding to your portfolio is a tough task, which is why the analysts at The Motley Fool have written a free and without obligation guide called 10 Steps To Making A Million In The Market.
It’s a simple and straightforward guide that could make a real difference to your portfolio returns and enable you to find the fastest growing companies at the lowest prices.
Click here to get your copy of the guide – it’s completely free and comes without any obligation.
Champion Shares PRO closes to new members at 11:59pm TONIGHT!
Click here for your last-chance invitation to claim YOUR seat alongside Nathan Parmelee as he aims to deliver yet another stellar performance that could take YOU all the way to financial independence.
Hurry there are fewer than 113 PRO Premiere seats remaining, and they’re being allocated on a first come, first served basis. I urge you to respond immediately to secure YOUR spot, because once they’re gone, they’re gone. Please CLICK HERE now to join PRO before the doors slam shut